View in EDS

Prognostic value of the Scottish Inflammatory prognostic Score in patients with NSCLC expressing PD-L1 ≥ 50 % progressing on first-line pembrolizumab.

Saved in:

Bibliographic Details
Title:	Prognostic value of the Scottish Inflammatory prognostic Score in patients with NSCLC expressing PD-L1 ≥ 50 % progressing on first-line pembrolizumab.
Authors:	Stares, Mark^1,2 (AUTHOR) mark.stares@ed.ac.uk, Doyle, Emma¹ (AUTHOR), Chapple, Sally¹ (AUTHOR), Raynes, George¹ (AUTHOR), MacDonald, James¹ (AUTHOR), Barrie, Colin¹ (AUTHOR), Laird, Barry^1,2 (AUTHOR), MacKean, Melanie¹ (AUTHOR), Philips, Iain^1,2 (AUTHOR)
Source:	Lung Cancer (01695002). Mar2024, Vol. 189, pN.PAG-N.PAG. 1p.
Database:	Academic Search Ultimate

Description
ISSN:	01695002
DOI:	10.1016/j.lungcan.2024.107497